Literature DB >> 15111087

Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms.

K Rose1, J Curtis, T Baldwin, A Mathis, B Kumar, A Sakthianandeswaren, T Spurck, J Low Choy, E Handman.   

Abstract

This is the first report of cutaneous leishmaniasis in kangaroos where infection was acquired within Australia. The diagnosis is based on the clinical criteria used for humans, the lesion histopathology, the detection and isolation of parasites from the lesions, and the analysis of the small subunit ribosomal RNA genes using the polymerase chain reaction. Despite a clear indication that the parasites belong to the genus Leishmania, no assignation to a known Leishmania species could be made using these or other less conserved genetic loci such as the non-transcribed spacer of the mini-exon repeat. As is the case in humans, some but not all animals harbouring lesions had antibodies to the isolated parasites or to several other Leishmania species. The isolated parasites displayed two well characterised Leishmania glycoconjugates, the lipophosphoglycan and proteophosphoglycan. They were infectious for mouse macrophages in vitro and established long-term infection at 33 degrees C but not at 37 degrees C. Our findings raise the possibility of transmission to humans, which may be unrecognised and suggest the possibility that imported species of Leishmania could become endemic in Australia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111087     DOI: 10.1016/j.ijpara.2004.03.001

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  27 in total

1.  Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient.

Authors:  D Stark; S Pett; D Marriott; J Harkness
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network.

Authors:  T Weitzel; N Mühlberger; T Jelinek; M Schunk; S Ehrhardt; C Bogdan; K Arasteh; T Schneider; W V Kern; G Fätkenheuer; G Boecken; T Zoller; M Probst; M Peters; T Weinke; S Gfrörer; H Klinker; M-L Holthoff-Stich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

3.  Phlebotomine sandflies and factors associated with their abundance in the leishmaniasis endemic area of Attiki, Greece.

Authors:  Sofia Boutsini; Labrini V Athanasiou; Gregory Spanakos; Dimitra Ntousi; Eleni Dotsika; Marina Bisia; Elias Papadopoulos
Journal:  Parasitol Res       Date:  2017-11-10       Impact factor: 2.289

4.  Case Reports: Late Emergence of Cutaneous Leishmaniasis in an Immunocompromised Patient in a Non-Endemic Setting.

Authors:  David New; Benjamin A Rogers
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

5.  Teaching Wildlife Disease Outbreak Response Through a Collaborative One Health Workshop.

Authors:  Elliott S Chiu; Justin Lee; Jennifer Malmberg; Anna Fagre; Nicholas G Dannemiller; Margot Stuchin; Ben Golas; Kathryn P Huyvaert
Journal:  J Vet Med Educ       Date:  2019-11-15       Impact factor: 1.027

6.  Leishmaniasis Vaccine: Where are We Today?

Authors:  Lukasz Kedzierski
Journal:  J Glob Infect Dis       Date:  2010-05

7.  Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.

Authors:  Katherine Kedzierska; Joan M Curtis; Sophie A Valkenburg; Lauren A Hatton; Hiu Kiu; Peter C Doherty; Lukasz Kedzierski
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

Review 8.  Parasite zoonoses and wildlife: emerging issues.

Authors:  R C Andrew Thompson; Susan J Kutz; Andrew Smith
Journal:  Int J Environ Res Public Health       Date:  2009-02-13       Impact factor: 3.390

9.  Experimental transmission of Leishmania (Mundinia) parasites by biting midges (Diptera: Ceratopogonidae).

Authors:  Tomas Becvar; Barbora Vojtkova; Padet Siriyasatien; Jan Votypka; David Modry; Petr Jahn; Paul Bates; Simon Carpenter; Petr Volf; Jovana Sadlova
Journal:  PLoS Pathog       Date:  2021-06-11       Impact factor: 6.823

10.  Development of Leishmania vaccines: predicting the future from past and present experience.

Authors:  Joshua Muli Mutiso; John Chege Macharia; Maria Ndunge Kiio; James Maina Ichagichu; Hitler Rikoi; Michael Muita Gicheru
Journal:  J Biomed Res       Date:  2012-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.